Dis-Chem Pharmacies Limited (DCP.JO)
ZAc 3675.0
(-0.11%)
ZAc 3675.0
(-0.11%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 13.02 Billion ZAR | 12.46% |
| 2022 | 11.58 Billion ZAR | 8.36% |
| 2021 | 10.68 Billion ZAR | 4.43% |
| 2020 | 10.23 Billion ZAR | 23.74% |
| 2019 | 8.27 Billion ZAR | 22.91% |
| 2018 | 6.73 Billion ZAR | 23.67% |
| 2017 | 5.44 Billion ZAR | 14.18% |
| 2016 | 4.76 Billion ZAR | 10.07% |
| 2015 | 4.33 Billion ZAR | 94.05% |
| 2014 | 2.23 Billion ZAR | 14.33% |
| 2013 | 1.95 Billion ZAR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 13.34 Billion ZAR | 0.0% |
| 2023 FY | 13.02 Billion ZAR | 12.46% |
| 2023 Q2 | 12.37 Billion ZAR | 0.0% |
| 2023 Q1 | 12.37 Billion ZAR | 6.83% |
| 2023 Q4 | 13.02 Billion ZAR | 0.0% |
| 2023 Q3 | 13.02 Billion ZAR | 5.27% |
| 2022 Q1 | 11.19 Billion ZAR | 4.76% |
| 2022 Q2 | 11.19 Billion ZAR | 0.0% |
| 2022 Q3 | 11.58 Billion ZAR | 3.44% |
| 2022 Q4 | 11.58 Billion ZAR | 0.0% |
| 2022 FY | 11.58 Billion ZAR | 8.36% |
| 2021 Q3 | 10.68 Billion ZAR | 5.22% |
| 2021 Q1 | 10.15 Billion ZAR | -0.75% |
| 2021 Q4 | 10.68 Billion ZAR | 0.0% |
| 2021 Q2 | 10.15 Billion ZAR | 0.0% |
| 2021 FY | 10.68 Billion ZAR | 4.43% |
| 2020 Q3 | 10.23 Billion ZAR | 18.61% |
| 2020 Q2 | 8.62 Billion ZAR | 0.0% |
| 2020 FY | 10.23 Billion ZAR | 23.74% |
| 2020 Q4 | 10.23 Billion ZAR | 0.0% |
| 2020 Q1 | 8.62 Billion ZAR | 4.32% |
| 2019 Q1 | 8.18 Billion ZAR | 21.57% |
| 2019 FY | 8.27 Billion ZAR | 22.91% |
| 2019 Q4 | 8.27 Billion ZAR | 0.0% |
| 2019 Q3 | 8.27 Billion ZAR | 1.1% |
| 2019 Q2 | 8.18 Billion ZAR | 0.0% |
| 2018 Q3 | 8.57 Billion ZAR | 34.29% |
| 2018 FY | 6.73 Billion ZAR | 23.67% |
| 2018 Q1 | 6.38 Billion ZAR | 17.28% |
| 2018 Q2 | 6.38 Billion ZAR | 0.0% |
| 2018 Q4 | 6.73 Billion ZAR | -21.48% |
| 2017 FY | 5.44 Billion ZAR | 14.18% |
| 2017 Q1 | 4.93 Billion ZAR | 3.61% |
| 2017 Q2 | 4.93 Billion ZAR | 0.0% |
| 2017 Q3 | 5.44 Billion ZAR | 10.35% |
| 2017 Q4 | 5.44 Billion ZAR | -0.13% |
| 2016 Q3 | 4.76 Billion ZAR | 10.48% |
| 2016 Q4 | 4.76 Billion ZAR | 0.0% |
| 2016 FY | 4.76 Billion ZAR | 10.07% |
| 2016 Q2 | 4.31 Billion ZAR | -12.93% |
| 2016 Q1 | 4.95 Billion ZAR | 14.43% |
| 2015 FY | 4.33 Billion ZAR | 94.05% |
| 2015 Q2 | 557.85 Million ZAR | 0.0% |
| 2015 Q4 | 4.33 Billion ZAR | 0.0% |
| 2015 Q3 | 4.33 Billion ZAR | 676.21% |
| 2015 Q1 | 557.85 Million ZAR | 0.0% |
| 2014 FY | 2.23 Billion ZAR | 14.33% |
| 2014 Q2 | 487.91 Million ZAR | 0.0% |
| 2014 Q3 | 487.91 Million ZAR | 0.0% |
| 2014 Q4 | 557.85 Million ZAR | 14.33% |
| 2014 Q1 | 487.91 Million ZAR | 0.0% |
| 2013 FY | 1.95 Billion ZAR | 0.0% |
| 2013 Q4 | 487.91 Million ZAR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|